TGFBR1 and breast cancer: Breast cancer tumours in TGFBR1*6A carriers were also slightly more poorly differentiated, indicating that the TGFBR1*6A variant might be associated with tumour grade even though our material of grade III tumours (n=75), from the population-based cohort, is small and the association of borderline significance only.